Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
Clinical trial NCT00081315 · COMPLETED
Trial details
- NCT number
- NCT00081315
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.